How does Belmar Pharma Solutions pricing work?

A quote-driven model means the price is assembled from inputs you do not fully control or see up front. The biggest input is the 503A partner pharmacy's wholesale cost for each compounded medication, which varies by drug, strength, and vial size. On top of that sits whatever margin or fee structure the platform applies, plus operational costs like shipping and payment processing. Belmar Pharma Solutions frames its rates as volume-negotiated with no middleman markup, but without published numbers you cannot independently verify how those layers add up.

Because the number arrives after a sales process, your evaluation has to be question-driven. Ask for a written per-vial cost on your top three SKUs — typically semaglutide, tirzepatide, and your highest-volume hormone or peptide — and ask whether that price holds across refill cycles or resets at renegotiation. Ask what is included and what is billed separately, so the quoted line is the landed cost, not a starting point.

Fizy Health takes the opposite approach to the same category. Instead of a negotiated quote you receive after onboarding, it shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment. The drug cost passes through and the platform fee is named, so the landed number is visible the same day you sign up — no sales call required to see a price.

That difference matters most when you quote cash-pay patients. If you set patient pricing on semaglutide or tirzepatide, you need to know your per-vial cost before the consult, not after a contract. A pass-through model lets you build margin from a number you can see; a quote-only model asks you to commit before the number is confirmed.